Author Question: Tobacco abuse among persons with bipolar disorder is: a. relatively rare compared to other ... (Read 50 times)

khang

  • Hero Member
  • *****
  • Posts: 569
Tobacco abuse among persons with bipolar disorder is:
 
  a. relatively rare compared to other psychiatric disorders
  b. contraindicated when taking antimanic medications
  c. extremely common but not frequently addressed by psychiatric caregivers
  d. of minor concern to the psychiatric caregiver

Question 2

A female client with dissociative identity disorder asks a nurse about how she will receive treatment. Which is the most appropriate nursing response?
 
  A) In group therapy on an inpatient basis.
  B) In individual therapy on an outpatient basis.
  C) In a support group.
  D) In family therapy.



ryansturges

  • Sr. Member
  • ****
  • Posts: 338
Answer to Question 1

C
Tobacco abuse is extremely common among persons with bipolar disorder and is among the most dangerous associations, leading to loss of life and increased morbidity. There are only limited data on the frequency with which persons with bipolar disorder are offered smoking cessation counseling and treatment. In a study of psychiatric practice using the National Ambulatory Medical Care Survey, Himelhoch and Daumit (2003) report that clients with bipolar disorder were more likely to receive smoking-related counseling than were those with some other disorders.

Answer to Question 2

B



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

When blood is exposed to air, it clots. Heparin allows the blood to come in direct contact with air without clotting.

Did you know?

Fatal fungal infections may be able to resist newer antifungal drugs. Globally, fungal infections are often fatal due to the lack of access to multiple antifungals, which may be required to be utilized in combination. Single antifungals may not be enough to stop a fungal infection from causing the death of a patient.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

In inpatient settings, adverse drug events account for an estimated one in three of all hospital adverse events. They affect approximately 2 million hospital stays every year, and prolong hospital stays by between one and five days.

Did you know?

Multiple experimental evidences have confirmed that at the molecular level, cancer is caused by lesions in cellular DNA.

For a complete list of videos, visit our video library